Latest Breaking News On - Aflibercept eylea biosimilars - Page 1 : comparemela.com

A number of biosimilar options to treat the common retina diseases are in development globally. Here’s a highlight of 9 with supporting late-stage data.

South koreaP biocon biologicsAflibercept eylea biosimilarsChong kun dangRanibizumab lucentis biosimilarsSamsung bioepisMomenta pharmaceuticalsBiocon biologicsAge related macular degenerationDiabetic macular edemaAnti vegf